The future of research on antigen-antibody complexes in toxicology lies in integrating big data analytics and computational modeling to predict immune responses to new toxins and drugs. Personalized medicine, which tailors treatments based on individual immune profiles, holds promise for reducing adverse reactions and optimizing therapeutic interventions. Understanding the mechanisms of immune complex formation and resolution will continue to be a key focus in developing safer and more effective therapies.
